Caris Life Sciences and ConcertAI Expand Partnership to Create First-in-Class, Prospectively Matched Clinico-Genomic Research Platform

Contemporaneously Combining Comprehensive Molecular Profiling at Unprecedented Scale with Reference-standard Clinical Data Creates a Novel Platform to Advance Precision Oncology Research IRVING, Texas and CAMBRIDGE, Mass., June 1, 2023 /PRNewswire/ — Caris Life Sciences®(Caris), the leading molecular science, artificial intelligence (AI) and machine learning technology company actively developing and delivering innovative solutions to revolutionize healthcare, … Read more

The Caris Precision Oncology Alliance Welcomes Leading Cancer Center

Caris expands its extensive network of leading cancer institutions committed to improving patient outcomes through innovations in precision medicine IRVING, Texas, May 31, 2023 /PRNewswire/ — Caris Life Sciences®(Caris), the leading molecular science and technology company actively developing and delivering innovative solutions to revolutionize healthcare, announced today that Memorial Sloan Kettering Cancer Center (MSK), one … Read more

Powered by Its Industry-Leading Comprehensive Multi-Omic Database, Caris Life Sciences to Showcase Extensive Research at ASCO 2023

In collaboration with leading cancer centers, research results to be presented from 42 studies across more than 30 solid tumor types demonstrating Caris’ impact on precision medicine IRVING, Texas, May 23, 2023 /PRNewswire/ — Caris Life Sciences®(Caris), the leading molecular science and technology company actively developing and delivering innovative solutions to revolutionize healthcare, today announced that … Read more

The Caris Precision Oncology Alliance Welcomes Robert H. Lurie Comprehensive Cancer Center of Northwestern University

Lurie Cancer Center joins Caris’ extensive network of leading cancer institutions committed to improving patient outcomes through innovations in precision medicine IRVING, Texas, May 16, 2023 /PRNewswire/ — Caris Life Sciences®(Caris), the leading molecular science and technology company actively developing and delivering innovative solutions to revolutionize healthcare, announced today that Robert H. Lurie Comprehensive Cancer … Read more